نتایج جستجو برای: neuromyelitis

تعداد نتایج: 2169  

Journal: :Journal of neurology, neurosurgery, and psychiatry 1997
H Cock R Mandler W Ahmed A H Schapira

Devic's neuromyelitis optica is a rare syndrome characterised by the combination of acute or subacute optic neuritis and transverse myelitis, in some cases considered to be a variant of multiple sclerosis. Mutations of mitochondrial DNA (mtDNA) associated with Leber hereditary optic neuropathy (LHON) have been identified in some patients with multiple sclerosis in whom optic neuritis is a promi...

Journal: :The Israel Medical Association journal : IMAJ 2011
Meri Matijaca Sanda Pavelin Dusanka Martinović Kaliterna Lovro Bojić Ana Matijaca

clinical examination, magnetic resonance imaging, cerebrospinal findings and positive aquaporin-4 antibodies, which are highly specific and sensitive for this condition. The serum autoantibody NMO-immunoglobulin G was reported as a biomarker of neuromyelitis optica in 2004. Viral prodrome often precedes the onset of disease, suggesting that infectious agents may cause or trigger NMO. Many disea...

Journal: :Archives of neurology 2011
Adi Vaknin-Dembinsky Oded Abramsky Panayiota Petrou Tamir Ben-Hur Marc Gotkine Livnat Brill Talma Brenner Zohar Argov Dimitrios Karussis

BACKGROUND Although overt involvement of the central nervous system (CNS) in myasthenia gravis (MG) is considered rare, hyperreflexia is a common and yet unexplained finding. Aquaporin 4 (AQP4), the target autoantigen in neuromyelitis optica, is expressed both in the CNS and in the neuromuscular junction. OBJECTIVES To evaluate the prevalence of even mild CNS involvement in patients with MG a...

Journal: :Arquivos de neuro-psiquiatria 2008
Tarso Adoni Angelina Maria Martins Lino Paulo Eurípedes Marchiori Fernando Kok Dagoberto Callegaro

OBJECTIVE To determine the seroprevalence of neuromyelitis optica antibody (NMO)-IgG in Brazilian patients with clinical diagnosis of relapsing neuromyelitis optica, also known as Devic's disease. METHOD We determined NMO-IgG titers in 28 patients (25 of them females) that fulfilled the 1999 NMO diagnostic criteria proposed by Wingerchuk et al. RESULTS NMO-IgG was detected in 18 NMO patient...

2015
Thomas Rossel Anastasia Zekeridou Francois Ochsner Susanne Renaud

Neuromyelitis optica (NMO) is an inflammatory disorder of the CNS with prominent involvement of the optic nerve and the spinal cord. An autoantibody against aquaporin-4 (AQP4), a water channel abundant on astrocytic foot processes, is the biomarker of the disease. The term neuromyelitis optica spectrum disorders (NMOSD) includes AQP4-IgG-positive syndromes that may only partially fulfill contem...

Journal: :Arquivos brasileiros de oftalmologia 2012
Luciano Mesquita Simão

Neuromyelitis optica antibody (or aquaporin-4 antibody) is a well established serum marker associated to high-risk neuromyelitis optica syndrome that presents as an inflammatory demyelinating disease characterized by the occurrence of bilateral and simultaneous optic neuritis without complete visual recovery or it occurs as an isolated episode of transverse myelitis accompanied by longitudinall...

Journal: :Arquivos de neuro-psiquiatria 2013
Luz Abaroa Sergio A Rodríguez-Quiroga Luciana Melamud Tomoko Arakaki Nelida S Garretto Andres M Villa

UNLABELLED Tonic spasms have been most commonly associated with multiple sclerosis. To date, few reports of series of patients with neuromyelitis optica and tonic spasms have been published. METHODS We analyzed the characteristics and frequency of tonic spasms in 19 subjects with neuromyelitis optica. Data was collected using a semi-structured questionnaire for tonic spasms, by both retrospec...

2015
Brian G. Weinshenker Gerard Barron Jacinta M. Behne Jeffery L. Bennett Peter S. Chin Bruce A.C. Cree Jerome de Seze Armando Flor Kazuo Fujihara Benjamin Greenberg Sayumi Higashi William Holt Omar Khan Volker Knappertz Michael Levy Angela T. Melia Jacqueline Palace Terry J. Smith Maria Pia Sormani Katja Van Herle Susan VanMeter Pablo Villoslada Marc K. Walton Warren Wasiewski Dean M. Wingerchuk Michael R. Yeaman

Current management of neuromyelitis optica (NMO) is noncurative and only partially effective. Immunosuppressive or immunomodulatory agents are the mainstays of maintenance treatment. Safer, better-tolerated, and proven effective treatments are needed. The perceived rarity of NMO has impeded clinical trials for this disease. However, a diagnostic biomarker and recognition of a wider spectrum of ...

Journal: :Rinsho Shinkeigaku 2012

2014
De-Hyung Lee Alexandra B Laemmer Anne Waschbisch Tobias Struffert Christian Maihöfner Stefan Schwab Ralf Andreas Linker

INTRODUCTION Neuromyelitis optica is an inflammatory demyelinating disease of the central nervous system. To date, optimal therapeutic approaches for neuromyelitis optica have yet to be defined. Natalizumab is highly effective in relapsing-remitting multiple sclerosis and might be considered as an option. CASE PRESENTATION Here, we describe a 67-year-old Caucasian man with definite neuromyeli...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید